lactic acid has been researched along with (n,n-bis(2-chloroethyl))-2-aminoethyl-3-((acridin-9-yl)amino)propionate in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Erickson, A; Hyland, RA; Johnson, L; Kwok, M; Marks, DC; Mufti, N; Vidovic, D; Winter, KM | 1 |
1 other study(ies) available for lactic acid and (n,n-bis(2-chloroethyl))-2-aminoethyl-3-((acridin-9-yl)amino)propionate
| Article | Year |
|---|---|
Red blood cell in vitro quality and function is maintained after S-303 pathogen inactivation treatment.
Topics: 2,3-Diphosphoglycerate; Acridines; Adenosine Triphosphate; Alkylating Agents; Blood Preservation; Blood Safety; Blood-Borne Pathogens; Erythrocyte Count; Erythrocytes; Glucose; Hemoglobins; Hemolysis; Humans; Lactic Acid; Microbial Viability; Nitrogen Mustard Compounds | 2014 |